XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Redeemable Noncontrolling Interest and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
IPO
Class A and Class B Common Stock
Class A and Class B Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Other Comprehensive Loss
Accumulated Deficit
Redeemable Noncontrolling Interest
Convertible Preferred Stock
Convertible Preferred Stock
Convertible Preferred Stock
Convertible Preferred Stock
IPO
Balance at beginning of period at Dec. 31, 2020                 $ 309    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss                 (54)    
Balance at end of period at Mar. 31, 2021                 255    
Balance at beginning of period (in shares) at Dec. 31, 2020     226,364,401             109,090,908  
Balance at beginning of period at Dec. 31, 2020 $ (158,545)   $ 7   $ 453,655   $ 604 $ (1,012,400)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises and vesting of early exercised Class A common stock options (in shares)     1,232,156                
Stock issued in connection with equity awards 10,143       10,143            
Repurchases of stock (in shares)     (214,509)                
Stock-based compensation 29,667       29,667            
Other comprehensive loss, net (721)           (721)        
Net loss (10,521)             (10,521)      
Balance at end of period (in shares) at Mar. 31, 2021     227,382,048             109,090,908  
Balance at end of period at Mar. 31, 2021 (129,977)   $ 7   493,465   (117) (1,022,921)   $ 399,589  
Balance at beginning of period at Dec. 31, 2020                 309    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss 113                    
Balance at end of period at Jun. 30, 2021                 196    
Balance at beginning of period (in shares) at Dec. 31, 2020     226,364,401             109,090,908  
Balance at beginning of period at Dec. 31, 2020 (158,545)   $ 7   453,655   604 (1,012,400)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss 3,902                    
Balance at end of period (in shares) at Jun. 30, 2021     372,165,319             0  
Balance at end of period at Jun. 30, 2021 1,997,441   $ 11   3,015,233   (9,305) (1,008,498)   $ 0  
Balance at beginning of period at Mar. 31, 2021                 255    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss 59               (59)    
Balance at end of period at Jun. 30, 2021                 196    
Balance at beginning of period (in shares) at Mar. 31, 2021     227,382,048             109,090,908  
Balance at beginning of period at Mar. 31, 2021 (129,977)   $ 7   493,465   (117) (1,022,921)   $ 399,589  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises and vesting of early exercised Class A common stock options (in shares)     1,020,588                
Stock issued in connection with equity awards 5,190       5,190            
Exercise of warrants, net of shares withheld (in shares)     6,229,081                
Issuance of Class A common stock in connection with acquisitions (in shares)     6,320,688                
Issuance of Class A common stock in connection with acquisitions 342,170       342,170            
Issuance of Class A common stock (in shares)     12,006                
Issuance of Class A common stock in connection with initial public offering, net of issuance costs as adjusted for cost reimbursement (in shares)     22,500,000                
Issuance of Class A common stock in connection with initial public offering, net of issuance costs as adjusted for cost reimbursement 1,747,971   $ 1   1,747,970            
Conversion of preferred stock to common stock in connection with initial public offering (in shares)       109,090,908             (109,090,908)
Conversion of preferred stock to common stock in connection with initial public offering   $ 0   $ 3   $ 399,586         $ (399,589)
Repurchases of stock (in shares)     (390,000)                
Stock-based compensation 26,852       26,852            
Other comprehensive loss, net (9,188)           (9,188)        
Net loss 14,423             14,423      
Balance at end of period (in shares) at Jun. 30, 2021     372,165,319             0  
Balance at end of period at Jun. 30, 2021 1,997,441   $ 11   3,015,233   (9,305) (1,008,498)   $ 0  
Balance at beginning of period at Dec. 31, 2021 201               201    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss                 (41)    
Balance at end of period at Mar. 31, 2022                 160    
Balance at beginning of period (in shares) at Dec. 31, 2021     375,089,360             0  
Balance at beginning of period at Dec. 31, 2021 2,138,090   $ 11   3,160,487   (45,454) (976,954)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises and vesting of early exercised Class A common stock options (in shares)     1,179,554                
Stock issued in connection with equity awards 6,541       6,541            
Shares withheld related to net share settlement (in shares)     (89,319)                
Shares withheld related to net share settlement (4,227)       (4,227)            
Repurchases of stock - repurchase program (in shares)     (893,556)                
Repurchases of stock - repurchase program (43,697)       (43,697)            
Stock-based compensation 44,377       44,377            
Other comprehensive loss, net (13,532)           (13,532)        
Net loss (115,257)             (115,257)      
Balance at end of period (in shares) at Mar. 31, 2022     375,286,039             0  
Balance at end of period at Mar. 31, 2022 2,012,295   $ 11   3,163,481   (58,986) (1,092,211)   $ 0  
Balance at beginning of period at Dec. 31, 2021 201               201    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss 92                    
Balance at end of period at Jun. 30, 2022 109               109    
Balance at beginning of period (in shares) at Dec. 31, 2021     375,089,360             0  
Balance at beginning of period at Dec. 31, 2021 2,138,090   $ 11   3,160,487   (45,454) (976,954)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net loss (137,005)                    
Balance at end of period (in shares) at Jun. 30, 2022     373,184,049             0  
Balance at end of period at Jun. 30, 2022 1,907,175   $ 11   3,149,474   (128,351) (1,113,959)   $ 0  
Balance at beginning of period at Mar. 31, 2022                 160    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net loss 51               (51)    
Balance at end of period at Jun. 30, 2022 109               $ 109    
Balance at beginning of period (in shares) at Mar. 31, 2022     375,286,039             0  
Balance at beginning of period at Mar. 31, 2022 2,012,295   $ 11   3,163,481   (58,986) (1,092,211)   $ 0  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Exercises and vesting of early exercised Class A common stock options (in shares)     1,194,805                
Stock issued in connection with equity awards 8,267       8,267            
Shares withheld related to net share settlement (in shares)     (234,412)                
Shares withheld related to net share settlement (9,384)       (9,384)            
Repurchases of stock - repurchase program (in shares)     (5,749,856)                
Repurchases of stock - repurchase program (210,830)       (210,830)            
Issuance of Class A common stock in connection with acquisitions (in shares)     2,579,692                
Issuance of Class A common stock in connection with acquisitions 137,422       137,422            
Issuance of common stock under employee stock purchase plan (in shares)     107,781                
Issuance of common stock under employee stock purchase plan 3,663       3,663            
Stock-based compensation 56,855       56,855            
Other comprehensive loss, net (69,365)           (69,365)        
Net loss (21,748)             (21,748)      
Balance at end of period (in shares) at Jun. 30, 2022     373,184,049             0  
Balance at end of period at Jun. 30, 2022 $ 1,907,175   $ 11   $ 3,149,474   $ (128,351) $ (1,113,959)   $ 0